Clinical Trial Update: Risk-adapted, MRD-directed Therapy for Young Adults With Newly Diagnosed Acute Myeloid Leukemia [Phase 2]

View source ↗

Summary

A Phase 2 trial updating risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Snippet

Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto | Conditions: Acute Myeloid Leukemia | Phase 2 | Status: COMPLETED